Related Experiment Video
Updated: Jul 2, 2026

Preparation and Characterization of C60/Graphene Hybrid Nanostructures
Published on: May 15, 2018
CHARISMA revisited: is the glass half full or just empty?
1Department of Neurology, Northwestern University Medical School, 710N Lake Shore Dr, Room 1122, Chicago, IL 60611, USA.
Combination therapy with aspirin and clopidogrel showed benefits for patients with symptomatic vascular disease, reducing stroke and heart attack risk. The therapy was not beneficial for those with only vascular disease risk factors.
Area of Science:
- Cardiology
- Vascular Medicine
- Clinical Trials
Background:
- The CHARISMA study evaluated dual antiplatelet therapy (aspirin plus clopidogrel) versus aspirin monotherapy in patients with established vascular disease or risk factors.
- The primary endpoint of the CHARISMA study did not demonstrate superiority for combination therapy in the overall population.
Purpose of the Study:
- To re-analyze CHARISMA study outcomes to identify differential treatment effects in patient subgroups.
- To investigate the efficacy and safety of aspirin plus clopidogrel compared to aspirin alone in symptomatic vascular disease patients versus those with only risk factors.
Main Methods:
- Retrospective analysis of the CHARISMA study data.
- Stratification of patients into two groups: symptomatic vascular disease and vascular disease risk factors only.
- Comparison of event rates (stroke, myocardial infarction, vascular death) and severe bleeding between treatment arms within each subgroup.
Main Results:
- Combination therapy did not significantly benefit patients with vascular disease risk factors only.
- Patients with symptomatic vascular disease experienced a statistically significant 12% relative risk reduction in stroke/myocardial infarction/vascular death with combination therapy versus aspirin alone.
- Severe bleeding events were not significantly increased in symptomatic patients receiving combination therapy compared to aspirin alone.
Conclusions:
- Dual antiplatelet therapy (aspirin plus clopidogrel) may be beneficial for high-risk patients with symptomatic vascular disease.
- Aspirin monotherapy may have a high failure rate in symptomatic vascular disease patients.
- It may be premature to discontinue combination therapy in symptomatic vascular disease populations based on subgroup analyses.
More Related Videos
09:35Preparation of a Corannulene-functionalized Hexahelicene by Copper(I)-catalyzed Alkyne-azide Cycloaddition of Nonplanar Polyaromatic Units
Published on: September 18, 2016
08:44Measurements of Long-range Electronic Correlations During Femtosecond Diffraction Experiments Performed on Nanocrystals of Buckminsterfullerene
Published on: August 22, 2017
Related Concept Videos
The Looking Glass Self
The Sense of Self: Reflected Self-Appraisal and Social Comparison
Self-Evaluation: Self-Enhancement and Self-Verification
The Representativeness Heuristic
Radicals: Electronic Structure and Geometry
Accordingly, the structure of a trivalent radical lies between the geometries of carbocations and carbanions. An sp2-hybridized carbocation is trigonal planar, while an sp3-hybridized carbanion is trigonal pyramidal. Here, the difference in geometry is...
Crystal Field Theory - Octahedral Complexes
To explain the observed behavior of transition metal complexes (such as colors), a model involving electrostatic interactions between the electrons from the ligands and the electrons in the unhybridized d orbitals of the central metal atom has been developed. This electrostatic model is crystal field theory (CFT). It helps to understand, interpret, and predict the colors, magnetic behavior, and some structures of coordination compounds of transition metals.
CFT focuses on...